Trial Profile
Safety and Therapeutic Effect of Human Amniotic Epithelial Cells in Severe Refractory Asherman's Syndrome
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Human amniotic epithelial cells-Shanghai-iCELL-Biotechnology (Primary) ; Human amniotic epithelial cells-Shanghai-iCELL-Biotechnology (Primary) ; Estrogen
- Indications Adhesions; Fibrosis; Uterine diseases
- Focus Therapeutic Use
- 28 Jul 2017 New trial record